New valve device aims to fix leaky heart valve without open surgery

NCT ID NCT05486832

Ongoing Disease control Sponsor: Cardiovalve Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study tests a new device called the Cardiovalve TR system to replace a leaky tricuspid valve in the heart. About 157 people with moderate to severe leakage and symptoms like shortness of breath are taking part. The goal is to see if the device is safe and can reduce the leak, helping patients feel better and walk farther.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Charité university

Berlin, 10117, Germany
Herzzentrum Uniklinik

Cologne, 50937, Germany
Uniklinik Bonn

Bonn, 53127, Germany
University Heart Center Lübeck

Lübeck, 20251, Germany
Universitäres Herz

Hamburg, 20251, Germany
Universität Bochum

Bad Oeynhausen, 32545, Germany
Universitätsklinikum - Regensburg

Regensburg, 93053, Germany

Conditions

Explore the condition pages connected to this study.

TRICUSPID REGURGITATION